山西省4地市乙肝及相关疾病直接费用及其影响因素分析  

Research on the direct costs and its influencing factors of the patients suffering from type B viral hepatitis and its related diseases in 4 towns of Shanxi province

作　　者：郭峰涛[1] 王小娟[1] 刘近春[1] 张顺祥[2] 刘宝芳[3] 程荣贵[4] 于建兰[4] 张爱国 胡日旺[6] 

机构地区：[1]山西医科大学第一医院消化内科,在读硕士研究生山西太原030001 [2]深圳市疾病预防控制中心,广东深圳518020 [3]太原市第三人民医院,山西太原030001 [4]长治医学院附属和济医院,山西长治046011 [5]山西省晋城市人民医院,山西晋城048026 [6]山西省大同市第四人民医院,山西大同037008

出　　处：《中国现代医生》2014年第10期10-14,共5页China Modern Doctor

基　　金：山西省太原市科技局项目(11016203)

摘　　要：目的估算山西省4地市乙肝及相关疾病的直接费用并分析其影响因素。方法采用整群抽样方法选择调查医院,利用问卷调查的方式获取直接费用及相关信息。采用EpiData 3.1软件双人平行录入建立数据库,采用SPSS 18.0统计软件进行分析。结果①乙肝患者年均直接费用分别为:急性乙肝19 345.77元,慢性乙肝24321.58元,乙肝后肝硬化27 761.35元,重型乙肝18 515.44元,原发性肝癌25 772.36元,其中药费所占的比例最大。②乙肝患者直接费用占家庭年收入56.86%,占人均收入205.54%,占例均GDP 68.73%。③4地市乙肝患者直接医疗费用、直接非医疗费用总体来说,差异有统计学意义(P<0.05)。④家庭月收入、是否抗病毒治疗、医保类型、疾病类型对乙肝患者年均直接费用的影响有统计学意义(P<0.05)。结论①乙肝相关疾病患者的直接费用仍很高。②乙肝相关疾病患者的直接费用对个人、家庭及社会带来了巨大的经济负担。③进一步调整收入分配,改善医疗保障制度有助于减轻乙肝患者及家庭的经济负担。Objective To estimate the direct costs of type B hepatitis and relates diseases in 4 towns of Shanxi province and explore its influencing factors. Methods Hospitals were randomly selected using cluster sampling method. We used questionnaire to acquire direct costs and related informations. Double parallel entry EpiData 3.1 software was adopted to establish the database. We used SPSS18.0 statistical software for analysis. Results 1.Annual average direct costs of type B hepatitis were respectively： acute hepatitis B： 19 345.77 yuan, chronic hepatitis B： 24 321.58 yuan, liv- er cirrhosis after hepatitis B： 27 761.35 yuan, heavy-duty hepatitis B： 18 515.44 yuan, primary liver cancer： 25 772.36 yuan. The largest proportion of the expenses was medical costs. 2.Direct costs of patients with type B hepatitis account- ed for 56.86% of the annual family income, 205.54% of the average per capita income and 68.73 % for average exam- ple GDP. 3.The difference between direct medical costs and direct non-medical costs of type B hepatitis patients in 4 towns was statistically significant （P 〈 0.05）. 4.The influence of family monthly income, whether accept antiviral treat- ment, health care types and disease types to the direct costs of type B hepatitis patients had statistically significant （P 〈 0.05）. Conclusion 1.The direct costs of patients with type B hepatitis related disease remained high. 2.The direct costs of patients with type B hepatitis related diseases had brought great economic burden to individuals, families and society. 3.Further adjustment of income distribution, improving the medical security system helps to reduce the eco- nomic burden of type B hepatitis patients and families.

关 键 词：乙型病毒性肝炎 直接费用 影响因素 

分 类 号：R512.62[医药卫生—内科学]